Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BLAC NASDAQ:LFWD NASDAQ:PAVM NASDAQ:STSS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBLACBellevue Life Sciences Acquisition$0.62+1.7%$0.82$3.01▼$13.40$2.51M-0.0822,626 shs201,288 shsLFWDLifeward$0.59+0.1%$0.67$0.50▼$4.00$9.18M0.16256,675 shs295,494 shsPAVMPAVmed$0.42-1.8%$0.51$0.30▼$1.90$9.39M1.09254,304 shs280,222 shsSTSSSharps Technology$9.12-1.9%$7.33$3.36▼$1,782.00$238.80M2.313.40 million shs685,264 shsThe 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBLACBellevue Life Sciences Acquisition0.00%+0.08%-1.76%-57.92%-94.52%LFWDLifeward+0.10%+10.38%-18.41%-46.82%-81.66%PAVMPAVmed-1.82%-5.70%-8.67%-34.21%-73.41%STSSSharps Technology-1.94%-15.08%+70.15%+67.34%+911,999,900.00%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBLACBellevue Life Sciences Acquisition$0.62+1.7%$0.82$3.01▼$13.40$2.51M-0.0822,626 shs201,288 shsLFWDLifeward$0.59+0.1%$0.67$0.50▼$4.00$9.18M0.16256,675 shs295,494 shsPAVMPAVmed$0.42-1.8%$0.51$0.30▼$1.90$9.39M1.09254,304 shs280,222 shsSTSSSharps Technology$9.12-1.9%$7.33$3.36▼$1,782.00$238.80M2.313.40 million shs685,264 shsThe 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBLACBellevue Life Sciences Acquisition0.00%+0.08%-1.76%-57.92%-94.52%LFWDLifeward+0.10%+10.38%-18.41%-46.82%-81.66%PAVMPAVmed-1.82%-5.70%-8.67%-34.21%-73.41%STSSSharps Technology-1.94%-15.08%+70.15%+67.34%+911,999,900.00%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBLACBellevue Life Sciences Acquisition 0.00N/AN/AN/ALFWDLifeward 3.00Buy$9.001,438.46% UpsidePAVMPAVmed 3.00Buy$19.004,422.73% UpsideSTSSSharps Technology 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBLACBellevue Life Sciences AcquisitionN/AN/AN/AN/AN/AN/ALFWDLifeward$25.66M0.36N/AN/A$2.14 per share0.27PAVMPAVmed$1.02M9.03N/AN/A($0.92) per share-0.46STSSSharps TechnologyN/AN/AN/AN/A$110.01 per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBLACBellevue Life Sciences AcquisitionN/AN/A0.00∞N/AN/AN/AN/AN/ALFWDLifeward-$28.94M-$3.12N/AN/AN/A-121.80%-137.91%-90.28%11/11/2025 (Estimated)PAVMPAVmed$39.79M$1.160.36N/AN/A7,144.80%N/A-20.96%11/12/2025 (Estimated)STSSSharps Technology-$9.30M-$1,212.34N/A∞N/AN/A-8.72%-5.30%N/ALatest BLAC, STSS, PAVM, and LFWD EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/14/2025Q2 2025LFWDLifeward-$0.25-$0.58-$0.33-$0.58$6.62 million$5.72 million8/13/2025Q2 2025STSSSharps Technology-$0.94$3.58+$4.52$3.58$0.25 million$0.22 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBLACBellevue Life Sciences AcquisitionN/AN/AN/AN/AN/ALFWDLifewardN/AN/AN/AN/AN/APAVMPAVmedN/AN/AN/AN/AN/ASTSSSharps TechnologyN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBLACBellevue Life Sciences AcquisitionN/AN/AN/ALFWDLifewardN/A2.001.26PAVMPAVmedN/A0.520.52STSSSharps TechnologyN/A4.353.67Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBLACBellevue Life Sciences Acquisition55.30%LFWDLifeward26.76%PAVMPAVmed19.93%STSSSharps Technology17.17%Insider OwnershipCompanyInsider OwnershipBLACBellevue Life Sciences Acquisition33.67%LFWDLifeward2.70%PAVMPAVmed7.30%STSSSharps Technology0.15%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBLACBellevue Life Sciences AcquisitionN/A4.04 million2.68 millionNot OptionableLFWDLifeward6015.70 million15.28 millionOptionablePAVMPAVmed9021.93 million20.33 millionOptionableSTSSSharps Technology325.68 million1.02 millionNot OptionableBLAC, STSS, PAVM, and LFWD HeadlinesRecent News About These CompaniesSharps Technology, Inc. (NASDAQ:STSS) Sees Large Increase in Short InterestSeptember 12 at 4:13 AM | americanbankingnews.comSolana Gets Institutional Boost from Sharps and Pudgy PenguinsSeptember 11 at 2:05 PM | coinlaw.ioCSharps Technology, Pudgy Penguins announce strategic partnershipSeptember 10 at 10:59 PM | msn.comSharps Technology and Pudgy Penguins Announce Strategic PartnershipSeptember 10 at 4:01 PM | prnewswire.comNew to The Street Signs Media Partnership with Sharps Technology (NASDAQ: STSS) as Company Announces Over $400M Solana (SOL) Treasury AcquisitionSeptember 4, 2025 | kansascity.comKSharps Technology acquires over 2 million SOLSeptember 2, 2025 | msn.comSharps Technology Enters Equity Sales AgreementSeptember 2, 2025 | tipranks.comSharps Technology, Inc. Acquires Over 2 Million SOL, the Native Asset of Solana, the Fastest and Most Used Public BlockchainSeptember 2, 2025 | tmcnet.comSharps Technology Inc: Sharps Technology, Inc. Acquires Over 2 Million SOL, the Native Asset of Solana, the Fastest and Most Used Public BlockchainSeptember 2, 2025 | finanznachrichten.deSharps Technology launches Solana treasury with $400M raise that could reach $1BAugust 29, 2025 | msn.comSharps Technology secures $400M, launches crypto treasuryAugust 29, 2025 | mobihealthnews.comMTimothy James Ruemler Sells 20,000 Shares of Sharps Technology (NASDAQ:STSS) StockAugust 29, 2025 | insidertrades.comSharps Technology, Inc. Closes Over $400 Million Private Placement, Launching Solana Digital Asset Treasury StrategyAugust 28, 2025 | prnewswire.comHere's why Sharps Technology stock jumped 56% on WednesdayAugust 27, 2025 | invezz.comISharps Technology, Inc. Stock (STSS) Opinions on $400M Solana Treasury AnnouncementAugust 27, 2025 | quiverquant.comQBrenda Baird Simpson Buys 20,000 Shares of Sharps Technology (NASDAQ:STSS) StockAugust 27, 2025 | insidertrades.comSharps Technology Stock Doubles After $400 Million Solana Treasury PlanAugust 27, 2025 | thecurrencyanalytics.comTSolana price prediction: SOL dips 10% despite treasury adoptionAugust 26, 2025 | coinjournal.netSharps Technology Stock Just Rocketed 54% Today – Here’s What HappenedAugust 26, 2025 | msn.comHealthcare stock surges 174% on suprise Solana treasury moveAugust 26, 2025 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeBLAC, STSS, PAVM, and LFWD Company DescriptionsBellevue Life Sciences Acquisition NASDAQ:BLAC$0.62 +0.01 (+1.66%) As of 09/12/2025Bellevue Life Sciences Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities in the healthcare industry. The company was incorporated in 2020 and is based in Bellevue, Washington. Bellevue Life Sciences Acquisition Corp. operates as a subsidiary of Bellevue Global Life Sciences Investors LLC.Lifeward NASDAQ:LFWD$0.58 +0.00 (+0.10%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$0.59 +0.01 (+0.85%) As of 09/12/2025 07:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke. The company markets and sells its products directly to institutions and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Illit, Israel.PAVmed NASDAQ:PAVM$0.42 -0.01 (-1.82%) Closing price 09/12/2025 03:57 PM EasternExtended Trading$0.44 +0.02 (+4.26%) As of 09/12/2025 05:25 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.PAVmed Inc. focuses on acquiring, developing, and commercializing novel products that target unmet needs in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; EsoCheck Esophageal Cell Collection Device, which consists of diagnostic test that serves as a testing tool for preventing esophageal adenocarcinoma deaths, through early detection of esophageal precancer in at-risk gastroesophageal reflux disease, including chronic heartburn and acid reflux or simply reflux in patients; and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay performed on surface esophageal cells collected with EsoCheck. Its product pipeline also comprises EsoCure EsoCure Esophageal Ablation Device for treating dysplastic BE; PortIO, an implantable intraosseous vascular access device; and Veris cancer care platform. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is headquartered in New York, New York.Sharps Technology NASDAQ:STSS$9.12 -0.18 (-1.94%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$9.25 +0.13 (+1.43%) As of 09/12/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Sharps Technology, Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. Sharps Technology, Inc. was incorporated in 2017 and is based in Melville, New York. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 09/08 - 09/12 Meta's $600B U.S. Investment: Bearish or Bullish for Shares? Post Onum Deal: Is CrowdStrike Ready to Rebound After 16% Drop? Chewy’s September Pullback: Is It Your Time to Buy? It’s Time to Buy the Dip in Kroger Stock Price Is Coupang the Next MercadoLibre? A Playbook for Global Dominance Vanguard’s VUG ETF: The Ultimate Growth ETF for Your Portfolio Tesla's U.S. Market Is At An 8-Year Low... How Bad Could It Get? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
